AbbVie buys ImmunoGen in US$10 billion deal, gains access to ADC for ovarian cancer. The ADC space gets hotter...
Up To Date
Latest News
Generative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led...
British and Italian researchers have demostrated promising results in patients with progressive multiple...
French Sanofi SA’s second Phase III trial of duplimab demonstrated a 34% reduction in exacerbations and...
In the race for global market share of its obesity and diabetes blockbuster semaglutide, Novo Nordisk is...
Flagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at ...